While Bavarian Nordic’s vaccine Jynneos is approved in several countries to prevent mpox and smallpox infections in adults, there has been a lack of data to support its approval in adolescents.

The World Health Organization approved Bavarian Nordic’s mpox vaccine for adolescents, according to a situation report. WHO says it “granted prequalification of the age-extension of the modified ...

(Reuters) -The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to ...